Key Organics Joins Proteom Limited In Prolysis' Drug Discovery Program
10/19/2005 5:09:24 PM
Key Organics Ltd of Cornwall UK has been selected as the latest strategic partner to work with Prolysis Ltd and Proteom Ltd in the optimization of Prolysis’ lead antibiotic programmes. Prolysis leads the industry in the discovery and development of novel inhibitors of bacterial cell division and has been working closely with Proteom since November 2004. The new triumvirate partnership will be working together specifically to tackle the critical problem of drug resistant bacterial infections.
comments powered by